Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity

Gene

Volumn 537, Issue 1, 2014, Pages 85-92

  Remely, Marlene ^a   Aumueller, Eva ^a   Merold, Christine ^a   Dworzak, Simone ^a   Hippe, Berit ^a   Zanner, Julia ^a   Pointner, Angelika ^a   Brath, Helmut ^b   Haslberger, Alexander G ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Health Center South   (Austria)

Author keywords

Butyryl CoA:acetate CoA transferase gene; Faecalibacterium prausnitzii; FFAR3; GLP 1 agonist; LINE 1

Indexed keywords

ACYLTRANSFERASE; BISULFITE; BUTYRYL COENZYME A ACETIC ACID COENZYME A TRANSFERASE; DNA 16S; EXENDIN 4; FREE FATTY ACID RECEPTOR 3; HEMOGLOBIN; LIRAGLUTIDE; RECEPTOR; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLOSTRIDIALES; CLOSTRIDIUM; CONTROLLED STUDY; CPG ISLAND; DIABETIC PATIENT; DIET SUPPLEMENTATION; DNA METHYLATION; EPIGENETICS; FAECALIBACTERIUM PRAUSNITZII; FATTY ACID SYNTHESIS; FECES ANALYSIS; FEMALE; FIRMICUTES; GLUCAGON RELEASE; HIGH THROUGHPUT SEQUENCING; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLALES; LEAN BODY WEIGHT; LONG INTERSPERSED REPEAT; MALE; MICROBIAL DIVERSITY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL COUNSELING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROKARYOTES BY METABOLISM; PROMOTER REGION; PYROSEQUENCING; SATIETY; SHORT CHAIN FATTY ACID PRODUCING BACTERIUM; WEIGHT REDUCTION;

CLOSTRIDIUM; FAECALIBACTERIUM PRAUSNITZII;

AUSTRIAN NUTRITION SOCIETY; B.I.D.; BMI; BODY MASS INDEX; BUTYRYL-COA:ACETATE COA-TRANSFERASE GENE; CPG; CYTOSINE-GUANINE DINUCLEOTIDE; DENATURING GRADIENT GEL ELECTROPHORESIS; DGGE; DRUG OVERDOSE; FAECALIBACTERIUM PRAUSNITZII; FFAR; FFAR3; FFQ; FOOD FREQUENCY QUESTIONNAIRE; FREE FATTY ACID RECEPTOR; G-PROTEIN COUPLED RECEPTOR; GLP-1; GLP-1 AGONIST; GLUCAGON LIKE PEPTIDE-1; GLYCOL HEMOGLOBIN; GPR; HBA(1C); HDAC; HISTONE DEACETYLASE; IFN-Γ; IL; INTERFERON-Γ; INTERLEUKIN; KEGG; KYOTO ENCYCLOPEDIA OF GENES AND GENOMES; LAT. BIS IN DIE (TWO TIMES PER DAY); LCFA; LINE-1; LIPOPOLYSACCHARIDE; LONG CHAIN FATTY ACID; LONG INTERSPERSED NUCLEAR ELEMENT 1; LPS; NF-ΚB; NUCLEAR FACTOR ΚB; O.D.; OEGE; PCA; PEPTIDE YY; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-Γ; PPAR-Γ; PRINCIPAL COMPONENT ANALYSIS; PYY; SCFA; SHORT CHAIN FATTY ACID; T; TIME POINT;

ADULT; AGED; BIODIVERSITY; BODY MASS INDEX; CASE-CONTROL STUDIES; COENZYME A-TRANSFERASES; DIABETES MELLITUS, TYPE 2; DNA METHYLATION; EPIGENESIS, GENETIC; FATTY ACIDS, VOLATILE; FECES; FEMALE; FOOD HABITS; GASTROINTESTINAL TRACT; GLUCAGON-LIKE PEPTIDE 1; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE ENDOSPORE-FORMING BACTERIA; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MICROBIOTA; MIDDLE AGED; OBESITY; PROMOTER REGIONS, GENETIC; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84892874108     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.11.081     Document Type: Article

References (50)

1. Association AD Executive Summary: Standards of Medical Care in Diabetes-2010. Diabetes J. 2010, 33(Supplement 1).
2. Baccarelli A., Tarantini L., Wright R.O., Bollati V., Litonjua A.A., et al. Repetitive element DNA methylation and circulating endothelial and inflammation markers in the VA normative aging study. Epigenetics 2010, 5.
3. Bergman E.N. Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol. Rev. 1990, 70:567-590.
4. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., et al. The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003, 278:11312-11319.
5. Canani R.B., Costanzo M.D., Leone L., Bedogni G., Brambilla P., et al. Epigenetic mechanisms elicited by nutrition in early life. Nutr. Res. Rev. 2011, 24:198-205.
6. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
7. de Kort S., Keszthelyi D., Masclee A.A. Leaky gut and diabetes mellitus: what is the link?. Obes. Rev. 2010, 12:449-458.
8. Delzenne N.M., Cani P.D. Interaction between obesity and the gut microbiota: relevance in nutrition. Annu. Rev. Nutr. 2011, 31:15-31.
9. Di J.Z., Han X.D., Gu W.Y., Wang Y., Zheng Q., et al. Association of hypomethylation of LINE-1 repetitive element in blood leukocyte DNA with an increased risk of hepatocellular carcinoma. J. Zhejiang Univ. Sci. B 2011, 12:805-811.
10. Diamant M., Blaak E.E., de Vos W.M. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?. Obes. Rev. 2011, 12:272-281.
11. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., et al. Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl. Environ. Microbiol. 2007, 73:1073-1078.
12. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., et al. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. (Lond) 2008, 32:1720-1724.
13. Duranton B., Keith G., Goss Bergmann C., Schleiffer R., et al. Concomitant changes in polyamine pools and DNA methylation during growth inhibition of human colonic cancer cells. Exp. Cell Res. 1998, 243:319-325.
14. Furet J.P., Kong L.C., Tap J., Poitou C., Basdevant A., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010, 59:3049-3057.
15. Gao Z., Yin J., Zhang J., Ward R.E., Martin R.J., et al. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58:1509-1517.
16. Gerritsen J., Smidt H., Rijkers G.T., de Vos W.M. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011, 6:209-240.
17. Halpern K.B., Veprik A., Rubins N., Naaman O., Walker M.D. PR41 Gene Expression Is Mediated by Internal Ribosome Entry Site (IRES)-dependent Translation of Bicistronic mRNA Encoding GPR40 and GPR41 Proteins. J. Biol. Chem. 2012, 287:20154-20174.
18. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., et al. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008, 27:104-119.
19. Hippe B., Zwielehner J., Liszt K., Lassl C., Unger F., et al. Quantification of butyryl CoA:acetate CoA-transferase genes reveals different butyrate production capacity in individuals according to diet and age. FEMS Microbiol. Lett. 2011, 316:130-135.
20. Ichimura A., Hirasawa A., Hara T., Tsujimoto G. Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis. Prostaglandins Other Lipid Mediat 2009, 89:82-88.
21. Karlsson F.H., Tremaroli V., Nookaew I., Bergstrom G., Behre C.J., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013, 498:99-103.
22. Kebede M.A., Alquier T., Latour M.G., Poitout V. Lipid receptors and islet function: therapeutic implications?. Diabetes Obes. Metab. 2009, 11(Suppl. 4):10-20.
23. Kootte R.S., Vrieze A., Holleman F., Dallinga-Thie G.M., Zoetendal E.G., et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes. Metab. 2012, 14:112-120.
24. Larsen N., Vogensen F.K., van den Berg F.W., Nielsen D.S., Andreasen A.S., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010, 5:e9085.
25. Layden B.T., Angueira A.R., Brodsky M., Durai V., Lowe W.L. Short chain fatty acids and their receptors: new metabolic targets. Transl. Res. 2012, 162:131-140.
26. Lin H.V., Frassetto A., Kowalik E.J., Nawrocki A.R., Lu M.M., et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012, 7:e35240.
27. Louis P., Flint H.J. Development of a semiquantitative degenerate real-time pcr-based assay for estimation of numbers of butyryl-coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl. Environ. Microbiol. 2007, 73:2009-2012.
28. Louis P., Flint H.J. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol. Lett. 2009, 294:1-8.
29. Macfarlane S., Macfarlane G.T. Regulation of short-chain fatty acid production. Proc. Nutr. Soc. 2003, 62:67-72.
30. Musso G., Gambino R., Cassader M. Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?. Diabetes Care 2010, 33:2277-2284.
31. Muyzer G., de Waal E.C., Uitterlinden A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 1993, 59:695-700.
32. Nauck M., Frid A., Hermansen K., Shah N.S., Tankova T., et al. Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study. Diabetes Care 2009, 32:84-90.
33. Neefs J.M., Van de Peer Y., De Rijk P., Goris A., De Wachter R. Compilation of small ribosomal subunit RNA sequences. Nucleic Acids Res. 1991, 19(Suppl.):1987-2015.
34. Pegorier J.P., Le May C., Girard J. Control of gene expression by fatty acids. J. Nutr. 2004, 134:2444S-2449S.
35. Pirker A., Stockenhuber A., Remely M., Harrant A., Hippe B., et al. Effects of antibiotic therapy on the gastrointestinal microbiota and the influence of Lactobacillus casei. Food Agric. Immunol. 2012, 1-16. 10.1080/09540105.2012.689816.
36. Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
37. Remely M., Dworzak S., Hippe B., Zwielehner J., Aumüller E., et al. Abundance and diversity of microbiota in type 2 diabetes and obesity. diabetes Metab. Res. Rev. 2013, 4.
38. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:16767-16772.
39. Schloegl H., Percik R., Horstmann A., Villringer A., Stumvoll M. Peptide hormones regulating appetite-focus on neuroimaging studies in humans. Diabetes Metab. Res. Rev. 2010, 27:104-112.
40. Schwiertz A., Taras D., Schafer K., Beijer S., Bos N.A., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 2010, 18:190-195.
41. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermudez-Humaran L.G., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:16731-16736.
42. Talukdar S., Olefsky J.M., Osborn O. Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases. Trends Pharmacol. Sci. 2011, 32:543-550.
43. Tremaroli V., Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
44. Tsukumo D.M., Carvalho B.M., Carvalho-Filho M.A., Saad M.J. Translational research into gut microbiota: new horizons in obesity treatment. Arq. Bras. Endocrinol. Metabol. 2009, 53:139-144.
45. Turcot V., Tchernof A., Deshaies Y., Perusse L., Belisle A., et al. LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clin. Epigenetics 2012, 4:10.
46. Turnbaugh P.J., Gordon J.I. The core gut microbiome, energy balance and obesity. J. Physiol. 2009, 587:4153-4158.
47. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
48. Vrieze A., Holleman F., Zoetendal E.G., de Vos W.M., Hoekstra J.B., et al. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 2010, 53:606-613.
49. Wu X., Ma C., Han L., Nawaz M., Gao F., et al. Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr. Microbiol. 2010, 61:69-78.
50. Wu J., Zhou Z., Hu Y., Dong S. Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. J. Genet. Genomics 2012, 39:375-384.